Poop pills could tame rare liver disease
NCT ID NCT06286709
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether transplanting healthy stool bacteria (FMT) can improve liver health in people with primary sclerosing cholangitis (PSC) and inflammatory bowel disease. 58 adults will receive either FMT or a placebo via colonoscopy and enemas. The main goal is to see if FMT lowers a key liver enzyme (ALP) after 48 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- fecal microbiota transplant (FMT)
- What this could lead to
- If it works, this could point toward a new treatment for primary sclerosing cholangitis (PSC) and related inflammatory bowel disease by restoring gut bacteria balance.
- What could go wrong
- This is an early phase 2 trial with only 58 participants, so results may not apply to everyone. FMT is generally safe but can cause mild side effects like bloating or infection risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust
RECRUITINGOxford, OX3 9DU, United Kingdom
-
King's College Hospital, King's College Hospital NHS Foundation Trust
RECRUITINGLondon, SE5 9RS, United Kingdom
-
Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust
RECRUITINGBirmingham, B15 2TH, United Kingdom
-
Royal Free Hospital, Royal Free London NHS Foundation Trust
RECRUITINGLondon, NW3 2QG, United Kingdom
-
St Mark's Hospital, London North West University Healthcare NHS Trust
RECRUITINGLondon, NW10 7NS, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug outperform standard care for a rare liver disease in teens?
- Can we predict how kids with IBD will respond to treatment?
- Could a new molecule tame a rare liver disease? early safety trial begins
- Blood test may tame the tightrope walk of transplant drugs
- Can a milk sugar tame IBD symptoms?
- Could an extra flu shot shield vulnerable kids?